Coherus succeeds in US pegfilgrastim suit

A US district court has adopted a magistrate judge’s earlier report recommending the dismissal of Amgen’s complaint against Coherus BioSciences for alleged infringement of a patent shielding the originator’s Neulasta (pegfilgrastim).